Medtronic (MDT) Receivables - Other (2015 - 2016)

Medtronic (MDT) reported Receivables - Other of $261.0 million for Q2 2016, down 11.82% on a YoY basis from $296.0 million in Q2 2015, and down 11.82% sequentially from $296.0 million in Q2 2015.

Medtronic (MDT) Receivables - Other (2015 - 2016) Analysis & Trends

Medtronic (MDT) has 2 years of Receivables - Other data on file, last reported at $261.0 million in Q2 2016.

  • For the quarter ending Q2 2016, Receivables - Other fell 11.82% year-over-year to $261.0 million; the trailing twelve-month figure through Apr 2016 stood at $261.0 million (down 11.82% YoY), and the FY2016 full-year result was $261.0 million, down 11.82% from the prior year.
  • Receivables - Other eased to $261.0 million in Q2 2016, from $296.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $296.0 million in Q2 2015 to a low of $261.0 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Apr 29, 2016 261.00 Mn
Apr 29, 2016 261.00 Mn
Apr 24, 2015 296.00 Mn
Apr 24, 2015 296.00 Mn